Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.760
-0.040 (-1.05%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Quantum BioPharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 3.31 | 2.76 | 16.98 | 35.26 | 17.52 | 5.97 | Upgrade
|
Short-Term Investments | 0.02 | 0.76 | - | 0.16 | - | - | Upgrade
|
Cash & Short-Term Investments | 3.33 | 3.51 | 16.98 | 35.42 | 17.52 | 5.97 | Upgrade
|
Cash Growth | -41.30% | -79.31% | -52.06% | 102.10% | 193.66% | -71.76% | Upgrade
|
Accounts Receivable | 6.48 | 7.19 | 0.02 | - | - | - | Upgrade
|
Other Receivables | 0.09 | 0.23 | 0.37 | 0.5 | 0.16 | 1.56 | Upgrade
|
Receivables | 6.56 | 7.42 | 0.4 | 0.5 | 0.16 | 1.56 | Upgrade
|
Inventory | - | - | - | - | - | 0.71 | Upgrade
|
Prepaid Expenses | 0.13 | 0.12 | 0.16 | 0.76 | 0.57 | 0.32 | Upgrade
|
Other Current Assets | - | 0.03 | 0.31 | 9.25 | 8.61 | - | Upgrade
|
Total Current Assets | 10.02 | 11.09 | 17.85 | 45.93 | 26.87 | 8.56 | Upgrade
|
Property, Plant & Equipment | 0.07 | 0.12 | 0.26 | 0.17 | - | 8.98 | Upgrade
|
Long-Term Investments | 0.01 | 0.01 | 0.83 | 0.66 | 1.68 | 8.86 | Upgrade
|
Other Intangible Assets | 5.15 | 5.36 | 12.04 | 16.2 | 13.42 | 16.82 | Upgrade
|
Long-Term Accounts Receivable | - | 0.91 | 7.43 | - | - | - | Upgrade
|
Total Assets | 15.25 | 17.47 | 38.41 | 62.96 | 41.97 | 43.22 | Upgrade
|
Accounts Payable | 3.6 | 3.24 | 2.76 | 3 | 2.06 | 3.29 | Upgrade
|
Accrued Expenses | 0.82 | 0.95 | 4.35 | 4.46 | 1.62 | 0.07 | Upgrade
|
Short-Term Debt | 0.62 | 0.3 | 0.3 | 0.3 | 0.38 | 1.44 | Upgrade
|
Current Portion of Leases | 0.01 | 0.04 | 0.18 | 0.12 | 0.05 | 0.04 | Upgrade
|
Other Current Liabilities | 0 | 0.03 | 0.24 | 0.83 | 1.46 | 1.99 | Upgrade
|
Total Current Liabilities | 5.04 | 4.57 | 7.83 | 8.7 | 5.58 | 6.83 | Upgrade
|
Long-Term Leases | - | - | 0.04 | 0.13 | 0.08 | 0.11 | Upgrade
|
Total Liabilities | 5.04 | 4.57 | 7.87 | 8.83 | 5.66 | 6.94 | Upgrade
|
Common Stock | 140.71 | 137.78 | 143.41 | 152.32 | 103.21 | 73.74 | Upgrade
|
Additional Paid-In Capital | 30.66 | 30.23 | 28.5 | 22.58 | 18.79 | 17.37 | Upgrade
|
Retained Earnings | -162.92 | -157.91 | -144.16 | -126.15 | -90.87 | -59.07 | Upgrade
|
Comprensive Income & Other | 2.52 | 3.14 | 2.8 | 5.38 | 5.18 | 4.24 | Upgrade
|
Total Common Equity | 10.96 | 13.24 | 30.54 | 54.13 | 36.31 | 36.28 | Upgrade
|
Minority Interest | -0.76 | -0.33 | - | - | - | - | Upgrade
|
Shareholders' Equity | 10.2 | 12.91 | 30.54 | 54.13 | 36.31 | 36.28 | Upgrade
|
Total Liabilities & Equity | 15.25 | 17.47 | 38.41 | 62.96 | 41.97 | 43.22 | Upgrade
|
Total Debt | 0.63 | 0.34 | 0.52 | 0.56 | 0.51 | 1.59 | Upgrade
|
Net Cash (Debt) | 2.7 | 3.17 | 16.46 | 34.86 | 17.01 | 4.38 | Upgrade
|
Net Cash Growth | -48.54% | -80.72% | -52.77% | 104.90% | 288.50% | -79.28% | Upgrade
|
Net Cash Per Share | 4.36 | 5.21 | 27.63 | 64.84 | 91.82 | 40.34 | Upgrade
|
Filing Date Shares Outstanding | 1.3 | 0.62 | 0.63 | 0.59 | 0.54 | 0.13 | Upgrade
|
Total Common Shares Outstanding | 0.73 | 0.61 | 0.59 | 0.62 | 0.29 | 0.12 | Upgrade
|
Working Capital | 4.98 | 6.52 | 10.02 | 37.23 | 21.29 | 1.73 | Upgrade
|
Book Value Per Share | 15.02 | 21.85 | 51.56 | 86.98 | 123.17 | 298.27 | Upgrade
|
Tangible Book Value | 5.81 | 7.88 | 18.5 | 37.93 | 22.88 | 19.46 | Upgrade
|
Tangible Book Value Per Share | 7.97 | 13.01 | 31.23 | 60.95 | 77.63 | 159.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.